PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
66.40%
Revenue growth above 1.5x MTDR's 39.00%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
139.84%
Gross profit growth at 50-75% of MTDR's 269.92%. Martin Whitman would question if cost structure or brand is lagging.
337.00%
EBIT growth below 50% of MTDR's 918.29%. Michael Burry would suspect deeper competitive or cost structure issues.
337.00%
Operating income growth under 50% of MTDR's 918.29%. Michael Burry would be concerned about deeper cost or sales issues.
237.14%
Net income growth at 50-75% of MTDR's 316.86%. Martin Whitman would question fundamental disadvantages in expenses or demand.
222.00%
EPS growth at 50-75% of MTDR's 313.33%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
222.00%
Diluted EPS growth at 50-75% of MTDR's 306.67%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
13.06%
Share count expansion well above MTDR's 3.18%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.06%
Diluted share count expanding well above MTDR's 1.38%. Michael Burry would fear significant dilution to existing owners' stakes.
-21.03%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.27%
OCF growth at 50-75% of MTDR's 128.32%. Martin Whitman would question if the firm lags in monetizing sales effectively.
175.36%
FCF growth above 1.5x MTDR's 58.95%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-70.29%
Negative 10Y revenue/share CAGR while MTDR stands at 1076.43%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-30.56%
Negative 5Y CAGR while MTDR stands at 56.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
246.05%
3Y revenue/share CAGR at 75-90% of MTDR's 322.47%. Bill Ackman would expect new product strategies to close the gap.
-74.80%
Negative 10Y OCF/share CAGR while MTDR stands at 101.51%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-36.62%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
569.07%
3Y OCF/share CAGR above 1.5x MTDR's 241.85%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-23.55%
Negative 10Y net income/share CAGR while MTDR is at 1470.51%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.47%
Negative 5Y net income/share CAGR while MTDR is 18.55%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
134.27%
3Y net income/share CAGR similar to MTDR's 127.42%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-77.54%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-21.07%
Negative 5Y equity/share growth while MTDR is at 29.68%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
25.10%
Below 50% of MTDR's 225.32%. Michael Burry suspects a serious short-term disadvantage in building book value.
-95.48%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-73.17%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
39.31%
3Y dividend/share CAGR of 39.31% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
5.50%
Our AR growth while MTDR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
0.29%
Asset growth well under 50% of MTDR's 4.69%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-14.50%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
2.84%
Debt shrinking faster vs. MTDR's 6.11%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-12.74%
We cut SG&A while MTDR invests at 8.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.